Susquehanna International Group, LLP Alpine Immune Sciences, Inc. Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$17.75 - $41.6 $1.55 Million - $3.62 Million	87,085 Added 382.37%	109,860 $4.35 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $194,498 - $460,510	22,775 New	22,775 $434,000
Q2 2023 Aug 11, 2023	BUY	$6.84 - $11.91 $5,588 - $9,730	817 Added 7.68%	11,451 $117,000
Q1 2023 May 16, 2023	SELL	$7.0 - $8.75 $80,696 - $100,870	-11,528 Reduced 52.02%	10,634 $82,000
Q4 2022 Feb 14, 2023	BUY	$5.45 - $7.35 $120,782 - $162,890	22,162 New	22,162 $162,000
Q2 2022 Aug 15, 2022	BUY	$6.71 - $9.52 $11,407 - $16,184	1,700 Added 13.69%	14,121 $120,000
Q1 2022 May 16, 2022	BUY	$6.41 - $13.89 $79,618 - $172,527	12,421 New	12,421 $111,000
Q2 2021 Aug 11, 2021	SELL	$8.81 - $15.03 $526,203 - $897,711	-59,728 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.02 - $13.92 $598,474 - $831,413	59,728 New	59,728 $633,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.